Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Sell
5,736
-629
-10% -$187K 0.02% 294
2025
Q4
$1.74M Sell
6,365
-14,624
-70% -$3.97M 0.02% 314
2025
Q3
$5.67M Buy
20,989
+14,189
+209% +$3.86M 0.07% 207
2025
Q2
$1.87M Sell
6,800
-125
-2% -$34K 0.03% 278
2025
Q1
$1.84M Sell
6,925
-216
-3% -$53.3K 0.03% 276
2024
Q4
$1.66M Sell
7,141
-80,782
-92% -$18.6M 0.02% 290
2024
Q3
$19.4M Buy
87,923
+75,808
+626% +$15.7M 0.29% 71
2024
Q2
$2.38M Sell
12,115
-4,146
-25% -$857K 0.1% 145
2024
Q1
$3.5M Sell
16,261
-44,804
-73% -$9.41M 0.14% 134
2023
Q4
$12.9M Sell
61,065
-710
-1% -$151K 0.28% 95
2023
Q3
$12.4M Buy
61,775
+23,751
+62% +$4.72M 0.27% 99
2023
Q2
$7.05M Buy
+38,024
New +$7.03M 0.17% 126

Other funds holding CME

LBP AM's CME Position: Q1 2026 in Review

LBP AM reduced its CME Group (CME) stake by 9.9% in Q1 2026, selling an estimated $187K and leaving 5,736 shares worth $1.69M. The position accounts for 0.02% of the portfolio, ranked #294.

LBP AM first reported a position in CME in Q2 2023 and has held it in 12 quarters since. The position peaked at $19.4M in Q3 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • LBP AM held 5,736 shares of CME Group worth $1.69M as of Q1 2026.
  • LBP AM sold 629 CME Group shares in Q1 2026, an estimated $187K.
  • CME Group made up 0.02% of LBP AM's portfolio in Q1 2026, its #294 holding.
  • LBP AM first reported a position in CME Group in Q2 2023 and has held it in 12 quarters since.
  • LBP AM's CME Group position peaked at $19.4M in Q3 2024.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.